+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Psoriasis Therapeutics Market Research Report by Molecule, by Route of Administration, by Dosage Forms, by Mechanism of Action - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5124004
  • Report
  • July 2020
  • Region: United States
  • 94 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amgen, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • Johnson & Johnson
  • Novartis AG
  • MORE
The United States Psoriasis Therapeutics Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Psoriasis Therapeutics Market.

Market Segmentation & Coverage:

This research report categorizes the Psoriasis Therapeutics market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Molecule, the Psoriasis Therapeutics Market studied across Biologics and Small Molecules.

Based on Route of Administration, the Psoriasis Therapeutics Market studied across Oral, Parenteral, and Topical.

Based on Dosage Forms, the Psoriasis Therapeutics Market studied across Liquid, Semi-solid, and Solid.

Based on Mechanism of Action, the Psoriasis Therapeutics Market studied across IL blocker, PDE4 Inhibitors, and TNF Inhibitors.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Psoriasis Therapeutics Market including Amgen, Inc., AstraZeneca, Eli Lilly and Company, Johnson & Johnson, and Novartis AG.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Psoriasis Therapeutics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Psoriasis Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Psoriasis Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Psoriasis Therapeutics Market?
4. What is the competitive strategic window for opportunities in the United States Psoriasis Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the United States Psoriasis Therapeutics Market?
6. What are the modes and strategic moves considered suitable for entering the United States Psoriasis Therapeutics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • Johnson & Johnson
  • Novartis AG
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Molecule Outlook
3.3. Route of Administration Outlook
3.4. Dosage Forms Outlook
3.5. Mechanism of Action Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Psoriasis Therapeutics Market, By Molecule
6.1. Introduction
6.2. Biologics
6.3. Small Molecules

7. United States Psoriasis Therapeutics Market, By Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Topical

8. United States Psoriasis Therapeutics Market, By Dosage Forms
8.1. Introduction
8.2. Liquid
8.3. Semi-solid
8.4. Solid

9. United States Psoriasis Therapeutics Market, By Mechanism of Action
9.1. Introduction
9.2. IL blocker
9.3. PDE4 Inhibitors
9.4. TNF Inhibitors

10. Competitive Strategic Window
10.1. Introduction
10.2. Competitive Strategic Window, by Molecule
10.3. Competitive Strategic Window, by Route of Administration
10.4. Competitive Strategic Window, by Dosage Forms
10.5. Competitive Strategic Window, by Mechanism of Action

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Amgen, Inc.
12.2. AstraZeneca
12.3. Eli Lilly and Company
12.4. Johnson & Johnson
12.5. Novartis AG

13. Appendix
13.1. Discussion Guide
13.2. Edition Details
13.3. License Details
13.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES PSORIASIS THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES PSORIASIS THERAPEUTICS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019 VS 2025 (USD MILLION)
FIGURE 7. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019 VS 2025 (USD MILLION)
FIGURE 8. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES PSORIASIS THERAPEUTICS MARKET, BY TYPE
FIGURE 9. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES PSORIASIS THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2019 VS 2025 (USD MILLION)
FIGURE 14. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2019 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MOLECULE, 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY DOSAGE FORMS, 2025 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 (USD MILLION)
FIGURE 19. UNITED STATES PSORIASIS THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 20. UNITED STATES PSORIASIS THERAPEUTICS MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY ORAL, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TOPICAL, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY LIQUID, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SEMI-SOLID, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY SOLID, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY IL BLOCKER, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY PDE4 INHIBITORS, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES PSORIASIS THERAPEUTICS MARKET SIZE, BY TNF INHIBITORS, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES PSORIASIS THERAPEUTICS MARKET: SCORES
TABLE 14. UNITED STATES PSORIASIS THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 15. UNITED STATES PSORIASIS THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 16. UNITED STATES PSORIASIS THERAPEUTICS MARKET: RANKING
TABLE 17. UNITED STATES PSORIASIS THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 18. UNITED STATES PSORIASIS THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 19. UNITED STATES PSORIASIS THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 20. UNITED STATES PSORIASIS THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 21. UNITED STATES PSORIASIS THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 22. UNITED STATES PSORIASIS THERAPEUTICS MARKET: EDITION DETAILS
TABLE 23. UNITED STATES PSORIASIS THERAPEUTICS MARKET: LICENSE DETAILS
TABLE 24. UNITED STATES PSORIASIS THERAPEUTICS MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
  • Amgen, Inc.
  • AstraZeneca
  • Eli Lilly and Company
  • Johnson & Johnson
  • Novartis AG
Note: Product cover images may vary from those shown
Adroll
adroll